GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Enzon Pharmaceuticals, Inc. (ENZN) [hlAlert]

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases. Enzon's specialized sales force markets ABELCET, ONCASPAR, ADAGEN, and DEPOCYT in the United States. In addition, Enzon
also receives royalties on sales of PEG-INTRON, marketed by Schering-Plough Corporation, and MACUGEN, marketed by OSI Pharmaceuticals and Pfizer Inc. Enzon's product-driven strategy includes an extensive drug development program that leverages its proprietary technologies, including a Customized Linker Technology PEGylation platform that utilizes customized linkers designed to release compounds at a controlled rate. Enzon also utilizes contract manufacturing opportunities to broaden its revenue base and enhance its organizational productivity. Enzon complements its internal research and development efforts with strategic initiatives.
( Total: 4 Current Stock Recommendations )
Enzon Pharmaceuticals, Inc.   (4)
Hold 50% Buy 50%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Hold ENZN
up 76.72 %

Rating:
Buy ENZN
down 89.88 %

Rating:
Buy ENZN
up 76.72 %

Rating:
Buy ENZN
down 81.91 %

Rating:
Hold ENZN
Icahn holds Enzon Inc
Sunday,  Nov 2, 2008  12:12 AM ET

Rating:
Buy ENZN
down 87.64 %

Your Recent Stocks
SymbolLastChange
ENZN 0.47 down  -55.47 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy